{"id":"https://openalex.org/W2947085753","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.4114","title":"Clinical efficacy and toxicity data on phase I study of fosbretabulin in combination with everolimus in neuroendocrine tumors.","display_name":"Clinical efficacy and toxicity data on phase I study of fosbretabulin in combination with everolimus in neuroendocrine tumors.","publication_year":2019,"publication_date":"2019-05-20","ids":{"openalex":"https://openalex.org/W2947085753","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.4114","mag":"2947085753"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.15_suppl.4114","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.4114","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.4114","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051388864","display_name":"Aman Chauhan","orcid":"https://orcid.org/0009-0003-0136-1983","observed_orcids":["https://orcid.org/0009-0003-0136-1983","https://orcid.org/0000-0002-4183-2116"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aman Chauhan","raw_affiliation_strings":["University of Kentucky, Division of Medical Oncology, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky, Division of Medical Oncology, Lexington, KY;","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030064179","display_name":"Susanne M. Arnold","orcid":"https://orcid.org/0000-0001-6542-9551","observed_orcids":["https://orcid.org/0000-0001-6542-9551"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]},{"id":"https://openalex.org/I2802239656","display_name":"Markey Cancer Center","ror":"https://ror.org/01dhvva97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285210727","https://openalex.org/I143302722","https://openalex.org/I2802239656"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susanne M. Arnold","raw_affiliation_strings":["Markey Cancer Center, University of Kentucky, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Markey Cancer Center, University of Kentucky, Lexington, KY;","institution_ids":["https://openalex.org/I143302722","https://openalex.org/I2802239656"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060308592","display_name":"Jianrong Wu","orcid":"https://orcid.org/0000-0002-3519-5894","observed_orcids":["https://orcid.org/0000-0002-3519-5894","https://orcid.org/0000-0003-2395-4619","https://orcid.org/0000-0002-5598-0478"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jianrong Wu","raw_affiliation_strings":["University of Kentucky, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky, Lexington, KY;","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005180505","display_name":"Rashmi T Nair","orcid":"https://orcid.org/0000-0001-6390-9877","observed_orcids":["https://orcid.org/0000-0001-6390-9877"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rashmi T Nair","raw_affiliation_strings":["University of Kentucky, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky, Lexington, KY;","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081279720","display_name":"Stacey A. Slone","orcid":"https://orcid.org/0000-0002-4355-7672","observed_orcids":["https://orcid.org/0000-0002-4355-7672"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]},{"id":"https://openalex.org/I2802239656","display_name":"Markey Cancer Center","ror":"https://ror.org/01dhvva97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285210727","https://openalex.org/I143302722","https://openalex.org/I2802239656"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stacey A. Slone","raw_affiliation_strings":["University of Kentucky Markey Cancer Center, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky Markey Cancer Center, Lexington, KY;","institution_ids":["https://openalex.org/I143302722","https://openalex.org/I2802239656"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084235817","display_name":"Emily Van Meter Dressler","orcid":"https://orcid.org/0000-0002-6054-7839","observed_orcids":["https://orcid.org/0000-0002-6054-7839"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]},{"id":"https://openalex.org/I2802239656","display_name":"Markey Cancer Center","ror":"https://ror.org/01dhvva97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285210727","https://openalex.org/I143302722","https://openalex.org/I2802239656"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Van Meter Dressler","raw_affiliation_strings":["University of Kentucky Markey Cancer Center, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky Markey Cancer Center, Lexington, KY;","institution_ids":["https://openalex.org/I143302722","https://openalex.org/I2802239656"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Heather Flynn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather Flynn","raw_affiliation_strings":["University of Kentucky, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky, Lexington, KY;","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112664150","display_name":"Val R. Adams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Val R. Adams","raw_affiliation_strings":["Univ of Kentucky, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Kentucky, Lexington, KY;","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023436882","display_name":"Heidi L. Weiss","orcid":"https://orcid.org/0009-0002-0980-7778","observed_orcids":["https://orcid.org/0009-0002-0980-7778"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]},{"id":"https://openalex.org/I2802239656","display_name":"Markey Cancer Center","ror":"https://ror.org/01dhvva97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285210727","https://openalex.org/I143302722","https://openalex.org/I2802239656"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heidi Weiss","raw_affiliation_strings":["University of Kentucky and Markey Cancer Center, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky and Markey Cancer Center, Lexington, KY;","institution_ids":["https://openalex.org/I143302722","https://openalex.org/I2802239656"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066347342","display_name":"Bernard Mark Evers","orcid":"https://orcid.org/0000-0002-9425-2342","observed_orcids":["https://orcid.org/0000-0002-9425-2342"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Evers","raw_affiliation_strings":["University of Kentucky, lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky, lexington, KY;","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005448318","display_name":"Lowell Brian Anthony","orcid":"https://orcid.org/0000-0001-7348-7874","observed_orcids":["https://orcid.org/0000-0001-7348-7874"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lowell Brian Anthony","raw_affiliation_strings":["University of Kentucky, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky, Lexington, KY;","institution_ids":["https://openalex.org/I143302722"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"15_suppl","first_page":"4114","last_page":"4114"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.9819999933242798},{"id":"https://openalex.org/keywords/neuroendocrine-tumors","display_name":"neuroendocrine tumors","score":0.972000002861023},{"id":"https://openalex.org/keywords/gastrointestinal-neuroendocrine-tumors","display_name":"gastrointestinal neuroendocrine tumors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/vascular-disrupting-agents","display_name":"vascular disrupting agents","score":0.9350000023841858},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.7360000014305115},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7699999809265137},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7979999780654907},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.8220000267028809},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7590000033378601},{"id":"https://openalex.org/keywords/metastatic-disease","display_name":"metastatic disease","score":0.7080000042915344},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5929999947547913},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.6079999804496765},{"id":"https://openalex.org/keywords/recist-response","display_name":"RECIST response","score":0.5370000004768372},{"id":"https://openalex.org/keywords/pneumonitis","display_name":"pneumonitis","score":0.6069999933242798}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9377496838569641},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.9138494729995728},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5689206123352051},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.511772096157074},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4873112142086029},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.46859684586524963},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.4561319947242737},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.44982096552848816},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.41782069206237793},{"id":"https://openalex.org/C2779066768","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine tumors","level":2,"score":0.4128651022911072},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40061792731285095},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3623213768005371},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3496977686882019},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18519526720046997}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.15_suppl.4114","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.4114","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.4114","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2954986240","https://openalex.org/W2890170672","https://openalex.org/W2243071171","https://openalex.org/W2062917093","https://openalex.org/W2590873469","https://openalex.org/W2591254987","https://openalex.org/W2589801633","https://openalex.org/W3135253998","https://openalex.org/W2796335748","https://openalex.org/W2518021910"],"abstract_inverted_index":{"4114":[0],"Background:":[1],"Fosbretabulin,":[2],"a":[3,33],"synthetic,":[4],"water-soluble,":[5],"phosphorylated":[6],"prodrug":[7],"of":[8,20,35,52,118,121,146,232,341,355],"the":[9,18,21,29,50,65,104,113,119,143,147,205,211,246,361,376],"natural":[10],"product":[11],"combretastatin":[12],"A4":[13],"(CA4P),":[14],"initially":[15],"isolated":[16],"from":[17],"bark":[19],"South":[22],"African":[23],"bush":[24],"willow,":[25],"Combretum":[26],"caffrum,":[27],"is":[28,46,245,375],"lead":[30],"compound":[31],"in":[32,78,125,238,261,286,335,387],"class":[34],"agents":[36,40],"termed":[37],"vascular":[38],"disrupting":[39],"(VDAs).":[41],"Everolimus,":[42],"an":[43],"mTOR":[44],"inhibitor,":[45],"FDA":[47],"approved":[48],"for":[49,136,186],"management":[51],"well-differentiated":[53],"NETs.":[54],"A":[55,345],"Phase":[56,67],"I":[57,91],"trial":[58,69,396],"combining":[59],"fosbretabulin":[60,124,244,372],"and":[61,74,123,165,266,279,297,352,384],"everolimus":[62,122,158,237,368],"to":[63,102,111,196,220,270,289,302,306],"determine":[64],"recommended":[66],"II":[68],"dose":[70,105,116,231],"(RP2D),":[71],"safety":[72,144],"data":[73,380],"early":[75],"clinical":[76,379,382],"efficacy":[77],"metastatic":[79,137],"GEPNET":[80],"patients":[81,207,283,310],"was":[82,110,169,194,216,300],"conducted.":[83],"Methods:":[84],"An":[85],"investigator-initiated,":[86],"single":[87],"center,":[88],"open-label,":[89],"phase":[90],"study":[92,271],"involving":[93],"GEPNETs":[94],"incorporated":[95],"partial":[96],"order":[97],"continual":[98],"reassessment":[99],"method":[100],"(PO-CRM)":[101],"define":[103],"escalation.":[106],"The":[107,229],"primary":[108],"objective":[109,140],"establish":[112],"maximum":[114],"tolerated":[115],"(MTD)":[117],"combination":[120,148,239],"NETs":[126],"that":[127],"have":[128],"progressed":[129],"after":[130],"at":[131,200,226,316,360,392],"least":[132],"one":[133,298,312,390],"prior":[134],"regimen":[135],"disease.":[138],"Secondary":[139],"included":[141],"identifying":[142],"profile":[145],"using":[149],"NCI":[150],"CTCAE4":[151],"reporting":[152],"criteria.":[153],"Patients":[154,183],"received":[155],"daily":[156,235,367],"oral":[157,236],"(2.5":[159],"mg,":[160,162,164],"5":[161,252,262],"7.5":[163],"10":[166,233],"mg).":[167],"Fosbretabulin":[168],"administered":[170],"IV":[171,243,373],"60":[172,370],"mg/m2":[173,371],"either":[174],"q3":[175],"weekly":[176,179,241,374],"or":[177,251],"q":[178],"based":[180],"on":[181],"PO-CRM.":[182],"were":[184,224,254,259],"treated":[185],"12":[187],"weeks":[188],"with":[189,240,348],"all":[190,349,388],"combinations.":[191],"RECIST":[192],"1.1":[193],"used":[195],"evaluate":[197],"radiological":[198],"responses":[199],"3":[201,257,317,393],"month.":[202],"Results:":[203],"Of":[204],"17":[206],"enrolled,":[208],"16":[209],"completed":[210],"12-week":[212],"trial.":[213],"One":[214,319,329],"patient":[215,299,320,330,391],"not":[217],"evaluable":[218,309],"due":[219,288,305],"noncompliance.":[221],"No":[222,248],"DLTs":[223],"observed":[225],"day":[227],"21.":[228],"highest":[230],"mg":[234,365],"60mg/m2":[242],"RP2D.":[247,377],"grade":[249,290,350],"4":[250],"toxicities":[253,258,351],"noted.":[255],"Grade":[256],"seen":[260],"patients;":[263],"abdominal":[264],"pain":[265],"hyperglycemia":[267],"(not":[268],"related":[269],"drug),":[272],"fatigue":[273],"(possibly":[274],"related),":[275],"decreased":[276],"lymphocyte":[277],"count":[278],"anemia":[280],"(related).":[281],"Several":[282],"had":[284,313,331],"delay":[285],"treatment":[287,304],"2":[291],"AE\u2019s":[292],"(GI":[293],"symptoms,":[294],"rash,":[295],"thrombocytopenia)":[296],"unable":[301],"complete":[303],"pneumonitis.":[307],"All":[308],"except":[311],"stable":[314,385],"disease":[315,386],"months.":[318,394],"showed":[321,343],"SD":[322],"but":[323,338,389],"non":[324],"target":[325],"lesion":[326],"demonstrated":[327],"PD.":[328],">":[332],"30%":[333],"decrease":[334],"tumor":[336],"size":[337],"overall":[339],"sum":[340],"lesions":[342],"SD.":[344],"detailed":[346],"table":[347],"waterfall":[353],"plot":[354],"RR":[356],"will":[357],"be":[358],"presented":[359],"meeting.":[362],"Conclusions:":[363],"Ten":[364],"PO":[366],"plus":[369],"Early":[378],"suggests":[381],"activity":[383],"Clinical":[395],"information:":[397],"NCT0301429.":[398]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2019-06-07T00:00:00"}